Our study primarily demonstrated the ability of LINC00472 to competitively bind to miR‐23a‐3p to boost the FOXO3 expression and transcriptionally activate the BID expression for suppression of pancreatic cancer progression. This evidence concerns the gene BID and pancreatic neoplasm.